IsofluraneDesfluraneBoosted the demand for inhalation anestheticsCAGRInhalational anesthesiaForecast periodPropofolIntravenousSurgeriesAnestheticInduction and maintenanceAnestheticsBaxter InternationalVolatile2018AdvantagesSurgical procedureHealthcare expenditureEtherPatient'sAnesthesiologistsSimplerPatientsAmbulatorySegmentComplicationsGeneralAttributableChronic diseasesAwarenessSurgeonsRisingGlobalShareDemandIndustryRisk
Isoflurane8
- If fresh gas flow rates are considered, sevoflurane and desflurane cost two to three times more than isoflurane. (grandviewresearch.com)
- Hence, isoflurane is the preferred choice for inhalation general anesthesia of anesthesiologists in developing countries owing to the presence of a cost-sensitive patient pool. (grandviewresearch.com)
- Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/sevofluraneisoflurane-desflurane-industry/ Market Drivers One of the primary factors, triggering expansion in the sevoflurane, isoflurane and desflurane market includes cardiovascular and respiratory diseases affecting the geriatric population. (paperzz.com)
- Universal insurance coverage as well as constant improvements in medical infrastructure also ensure the development of the sevoflurane, isoflurane and desflurane market. (paperzz.com)
- Sevoflurane would capture over 70% of the worldwide sevoflurane, isoflurane and desflurane market by 2022. (paperzz.com)
- Medical tourism combined with insurance coverage will play a huge role in sustaining the growth of the sevoflurane, isoflurane and desflurane market. (paperzz.com)
- Piramal Enterprises currently has isoflurane and sevoflurane production underway. (paperzz.com)
- AbbVie has sevoflurane and isoflurane under production. (paperzz.com)
Desflurane3
- Desflurane is a volatile, non-flammable and non-explosive agent extensively used in maintenance of general anesthesia. (gminsights.com)
- Advantages offered by desflurane such as low risk of nephrotoxicity and quick recovery as compared to sevoflurane will foster inhalation anesthesia market growth. (gminsights.com)
- Desflurane Desflurane is a halogen ether used in general anesthesia. (paperzz.com)
Boosted the demand for inhalation anesthetics1
- During the post-COVID-19 situation, there has been an increase in the number of elective surgeries, which has further boosted the demand for inhalation anesthetics. (grandviewresearch.com)
CAGR7
- The global inhalation anesthesia market size was valued at USD 1.46 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.04% from 2023 to 2030. (grandviewresearch.com)
- Inhalation Anesthesia Market size was valued at USD 1.3 billion in 2018 and is expected to witness 5.4% CAGR from 2019 to 2025. (gminsights.com)
- Press Release: Inhalation Anesthesia Market to Register a CAGR of 3.5% Over. (marketresearch.biz)
- The Global Inhalation Anesthesia Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031. (marketresearch.biz)
- The global Sevoflurane Market is estimated to be valued at US$370.2 million in 2022 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. (newsstatix.com)
- The global Sevoflurane Market is expected to witness high growth, exhibiting a CAGR of 4.4% over the forecast period. (newsstatix.com)
- According to a research report, published by Spherical Insights & Consulting, the global Sevoflurane Market Size to grow from USD 370.2 billion in 2021 to USD 1252.2 billion by 2030, at a CAGR of 4.5% during the forecast period. (sphericalinsights.com)
Inhalational anesthesia2
- For the same reason, we did not compare total IV anesthesia with total inhalational anesthesia because the latter strategy is seldom used in adult surgery , and previous trials also allowed for administration of IV anesthetics in the volatile anesthetics group. (medpagetoday.com)
- In addition, inhalational anesthesia helps avoid excessive dosage, keeps the patient's autonomic functions intact, prevents accumulation of drugs in the body and have limited tolerance and addiction level as compared to conventional routes. (marketresearch.biz)
Forecast period5
- Hence, higher patient benefits associated with the use of inhalation anesthesia as compared to intravenous version is expected to drive revenue growth over the forecast period. (grandviewresearch.com)
- Ambulatory surgical centers segment is projected to grow at the fastest rate over the forecast period as it is a specialized setting for conducting same-day surgeries, which requires inhalation anesthetics that have a fast effect and recovery time. (grandviewresearch.com)
- Additionally, faster recovery as compared to halothane and minimal risk of fulminant hepatitis will boost inhalation anesthesia business growth during the forecast period. (gminsights.com)
- The sevoflurane segment is projected to grow at a significant growth rate over the forecast period and maintain its dominance in the next 10 years. (marketresearch.biz)
- It is anticipated that inorganic activities such as collaborations, agreements, acquisitions, and others will be among the primary growth drivers of the global sevoflurane market throughout the forecast period. (sphericalinsights.com)
Propofol1
- In April of 2021, the University of Malaya, a public research university located in Kuala Lumpur, Malaysia, began a Phase 4 study to compare sevoflurane and propofol sedation in end-stage renal failure (ESRF) patients undergoing transposition of brachiocephalic fistula repair. (sphericalinsights.com)
Intravenous3
- Inhalation anesthesia facilitates higher patient outcomes as compared to intravenous route. (grandviewresearch.com)
- Various advantages of inhalation route over intravenous route are primarily driving the market growth. (grandviewresearch.com)
- Further, certain advantages offered by inhalation anesthesia such as low risk of adverse chemical reactions and lower chances of complications during administration as compared with Intravenous Anesthesia (IVA), makes the target product popular among medical practitioners. (marketresearch.biz)
Surgeries6
- In 2020, during the COVID-19 pandemic, the Centers for Medicare and Medicaid Services recommended that hospitals minimize, postpone, or cancel elective surgeries which have led to a reduction in the number of surgeries by 48% in the U.S. Inhaled anesthetics are commonly used to provide general anesthesia. (grandviewresearch.com)
- Hospitals segment dominated the market for inhalation anesthesia with a share of 68.54% in 2022, attributable to the highest number of surgeries performed in hospital settings. (grandviewresearch.com)
- Thus, growing demand for inhalation anesthetics during surgeries will favour business growth. (gminsights.com)
- Inhalation anesthesia is routinely used during most medical surgeries as the intensity of anesthesia is simpler to control and the patient regains his/her consciousness soon with few deleterious after-effects. (marketresearch.biz)
- Rising number of emergencies due to increasing number of accidental cases, chronic diseases, and cataract cases is expected to boost demand for surgeries, and subsequently need for anesthesia procedures. (marketresearch.biz)
- Additionally, sevoflurane offers smooth and predictable maintenance of anesthesia, reducing the risk of awareness during surgeries. (newsstatix.com)
Anesthetic6
- Life-saving surgical procedures such as brain surgery, open-heart surgery, or organ transplantation would not have been possible without general anesthesia, thereby, boosting the demand for inhaled anesthetic drugs. (grandviewresearch.com)
- Inhalation anesthesia is a surgical procedure in which an anesthetic compound is administered to patient via inhalation. (marketresearch.biz)
- The most practical solution for this problem is the anesthetic recycling of products used during the administration of general anesthesia. (paperzz.com)
- Products Overview Sevoflurane Sevoflurane is one of the most commonly used volatile anesthetic agents. (paperzz.com)
- The recycling companies of Deltasorb Technologies and Anesthetic Gas Reclamation reprocess anesthesia containers and gases from hospital vents. (paperzz.com)
- Sevoflurane is a commonly used inhalation anesthetic agent that provides an effective and safe method of inducing and maintaining general anesthesia for various surgical procedures. (newsstatix.com)
Induction and maintenance2
- These factors have led to sevoflurane being the preferred choice of surgeons during surgical procedures for induction and maintenance of anesthesia. (grandviewresearch.com)
- The sevoflurane market is categorized into induction and maintenance based on the application type. (sphericalinsights.com)
Anesthetics9
- Maintenance segment dominated the inhalation anesthesia industry with a share of 84.91% in 2022, attributable to the fact that inhaled anesthetics are preferred for the maintenance of anesthesia. (grandviewresearch.com)
- Moreover, benefits of inhalation anesthetics over injectable anesthetics will further stimulate inhalation anesthesia business growth. (gminsights.com)
- However, several adverse effects of anesthetics may impede inhalation anesthesia industry growth over the analysis timeframe. (gminsights.com)
- Induction of anesthesia necessitates higher concentration of drug as compared to the amount required for maintenance, thus increasing the demand for inhalation anesthetics. (gminsights.com)
- Segment growth is attributed to increasing demand for inhalation anesthetics due to airway safety airway and fast recovery as compared to injectable anesthetics. (gminsights.com)
- Secondly, the advantages offered by sevoflurane over other inhalation anesthetics, such as rapid onset and offset, low blood-gas solubility, and minimal metabolism in the body, make it a preferred choice among anesthesiologists. (newsstatix.com)
- Threat: The availability of alternative inhalation anesthetics and the potential for adverse effects associated with sevoflurane pose threats to market growth. (newsstatix.com)
- Sevoflurane is one of the general anesthetics included in the drugs referred to as anesthetics. (sphericalinsights.com)
- Although sevoflurane can be provided independently, it is usually combined with several other anesthetics. (sphericalinsights.com)
Baxter International1
- Browse All Pharmaceuticals Industry Research Related Reports @ http://www.hexaresearch.com/research-category/pharmaceuticals-industry/ Key Players The market is currently dominated by AbbVie and Baxter International. (paperzz.com)
Volatile1
- Weakness: Sevoflurane is a volatile liquid that requires special handling, storage, and administration techniques. (newsstatix.com)
20181
- Induction inhalation anesthesia market segment accounted for more than USD 250 million in 2018. (gminsights.com)
Advantages2
- Moreover, the rising awareness among healthcare professionals regarding the advantages of sevoflurane is driving its adoption in these regions. (newsstatix.com)
- Strength: Sevoflurane offers advantages such as rapid onset and offset, low blood-gas solubility, and minimal metabolism in the body. (newsstatix.com)
Surgical procedure1
- Based on NIH data, nearly 60,000 people undergo a surgical procedure under general anesthesia. (grandviewresearch.com)
Healthcare expenditure1
- Developing countries are witnessing a rise in healthcare expenditure and infrastructure development, leading to increased access to anesthesia services. (newsstatix.com)
Ether1
- Chemically, sevoflurane is an ether with low pungency, a low blood-gas partition co-efficient, and a non-irritant odor. (marketresearch.biz)
Patient's2
- Inhalation anesthesia is considered to be the best alternative for patients who are on ventilation for more than 24 hours as it becomes easy to monitor the patient's health. (grandviewresearch.com)
- Sevoflurane makes it easier to keep the patient's blood pressure and heart rate stable during the surgery. (sphericalinsights.com)
Anesthesiologists1
- These three chemicals are inhalation agents and have been used by anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. (paperzz.com)
Simpler1
- These agents are administered to patients prior surgery, making the induction of general anesthesia much simpler. (paperzz.com)
Patients4
- These patients do not require an overnight stay giving the inhaled anesthesia a competitive edge in the ambulatory surgical center setting. (grandviewresearch.com)
- Inhaled anesthesia may be safer for the heart than infusion agents, but that didn't lead to better survival in patients undergoing coronary artery bypass grafting (CABG) surgery in the MYRIAD trial . (medpagetoday.com)
- Sevoflurane most popular among surgeons and patients. (marketresearch.biz)
- Sevoflurane is ideal for patients with asthma or sensitive air passages. (paperzz.com)
Ambulatory1
- Surge in number of emergency and trauma cases and growing patient inclination towards ambulatory day care procedures will serve to be positive impact rendering factors augmenting inhalation anesthesia industry growth. (gminsights.com)
Segment2
- Currently, among segments based on product, the sevoflurane segment dominates in the global inhalation anesthesia market with major revenue share. (marketresearch.biz)
- Currently, among segments based on application, the maintenance segment dominates in the global inhalation anesthesia market. (marketresearch.biz)
Complications1
- For instance, sevoflurane has a short induction and emergence time, allowing for faster recovery and reduced post-operative complications. (newsstatix.com)
General2
- Those randomized to inhaled anesthesia had the same likelihood of mortality at 1 year as peers who got IV general anesthesia-only (2.8% vs 3.0%, RR 0.94, 95% CI 0.69-1.29). (medpagetoday.com)
- Sevoflurane is frequently used to deliver general anesthesia (awareness loss) before and during surgical procedures. (sphericalinsights.com)
Attributable1
- This can be attributable to higher requirement of anesthesia for maintenance as compared with induction. (marketresearch.biz)
Chronic diseases1
- The rise in the prevalence of chronic diseases and the aging population are leading to an increase in surgical interventions, thus boosting the demand for sevoflurane. (newsstatix.com)
Awareness1
- In terms of regional analysis, emerging economies such as India and China are expected to be among the fastest-growing and dominating regions in the market due to improving healthcare infrastructure and rising awareness about the benefits of sevoflurane. (newsstatix.com)
Surgeons2
- Inhalation anesthesia helps surgeons design the dosage to avoid additional hospital stay. (grandviewresearch.com)
- However, high cost of inhalation anesthesia procedure and lack of well-trained surgeons may hamper growth for the target market. (marketresearch.biz)
Rising1
- The increasing demand for anesthesia, driven by rising surgical procedures globally, is a key factor contributing to market growth. (newsstatix.com)
Global3
- Furthermore, increasing investments in R&D, by leading manufacturers in order to develop technologically advanced products such as airway pressure monitoring and breathing system disconnect alarms, monitoring of inspired oxygen, pulse oximetry, etc., is expected to support growth of the global inhalation anesthesia market in next 10 years. (marketresearch.biz)
- Currently, among segments based on region, the North America market accounts for a major share in the global inhalation anesthesia market in terms of revenue. (marketresearch.biz)
- One key trend in the Global Sevoflurane Market is the increasing adoption of sevoflurane in emerging economies. (newsstatix.com)
Share1
- This has led the region of North America to occupy the biggest share in the worldwide inhalation anesthesia market in 2014. (paperzz.com)
Demand3
- The increasing demand for anesthesia and the rise in surgical procedures worldwide are key factors driving the growth of the Sevoflurane Market. (newsstatix.com)
- Firstly, the growing number of surgical procedures globally is driving the demand for anesthesia, including sevoflurane. (newsstatix.com)
- This, in turn, is expected to fuel the demand for sevoflurane in these markets. (newsstatix.com)
Industry1
- Hexa Research Inc. Industry Research,Custom Research & Consulting Growing accidents and emergency cases also add income to the inhalation anesthesia market. (paperzz.com)
Risk1
- Several benefits offered by ASCs such as reduced risk of hospital acquired infections, quality treatment at affordable prices and shorter hospital stay will accelerate inhalation anesthesia business growth over the analysis period. (gminsights.com)